Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lou, Emil
207  Ergebnisse:
?
1

Mesothelin expression correlates with elevated inhibitory i..:

Malla, Midhun ; Deshmukh, Sachin Kumar ; Wu, Sharon...
Cancer Gene Therapy.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

A phase II study of FOLFOX combined with nab-paclitaxel in ..:

Dreyer, Marie S ; Mulcahy, Mary ; Kocherginsky, Masha...
The Oncologist.  , 2024
Link: https://doi.org/10.1093/..
 
?
3

Do tunneling nanotubes drive chemoresistance in solid tumor..:

Sarkari, Akshat ; Lou, Emil
Biochemical Society Transactions.  52 (2024)  4 - p. 1757-1764 , 2024
Link: https://doi.org/10.1042/..
 
?
4

Differential landscape of immune evasion in oncogenic RAS-d..:

Lou, Emil ; Xiu, Joanne ; Baca, Yasmine...
Molecular Therapy: Oncology.  32 (2024)  1 - p. 200786 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Predictive value of CDC37 gene expression for targeted ther..:

Arai, Hiroyuki ; Yang, Yan ; Baca, Yasmine...
European Journal of Cancer.  201 (2024)  - p. 113914 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable ..:

Miller, Carly D. ; Lozada, John R. ; Zorko, Nicholas A....
Cancer Research Communications.  4 (2024)  5 - p. 1369-1379 , 2024
Link: https://doi.org/10.1158/..
 
?
7

CCR5andCCL5gene expression in colorectal cancer: comprehens..:

Battaglin, Francesca ; Baca, Yasmine ; Millstein, Joshua...
Journal for ImmunoTherapy of Cancer.  12 (2024)  1 - p. e007939 , 2024
Link: https://doi.org/10.1136/..
 
?
8

Tunneling nanotubes and tumor microtubes—Emerging data on t..:

Lou, Emil ; Vérollet, Christel ; Winkler, Frank...
The FASEB Journal.  38 (2024)  5 - p. , 2024
Link: https://doi.org/10.1096/..
 
?
9

Molecular Landscape and Clinical Implication of CCNE1-ampli..:

Rustgi, Naryan ; Wu, Sharon ; Samec, Timothy...
Cancer Research Communications.  4 (2024)  6 - p. 1399-1409 , 2024
Link: https://doi.org/10.1158/..
 
?
10

Treatment with tumor-treating fields (TTFields) suppresses ..:

Sarkari, Akshat ; Korenfeld, Sophie ; Deniz, Karina...
eLife.  12 (2023)  - p. , 2023
Link: https://doi.org/10.7554/..
 
?
11

ERBB family fusions are recurrent and actionable oncogenic ..:

Schubert, Laura ; Elliott, Andrew ; Le, Anh T....
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
12

PBRM1 mutations might render a subtype of biliary tract can..:

Zimmer, Kai ; Kocher, Florian ; Untergasser, Gerold...
npj Precision Oncology.  7 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

Contributors:

, In: NK Cells in Cancer Immunotherapy: Successes and Challenges,
Abreu, Maria M. ; Adusumilli, Prasad S. ; Badie, Behnam... - p. xxvii-xxix , 2023
Link: https://doi.org/10.1016/..
 
?
14

Learning Outcomes of "GetSMART," Education for Diagnostics ..:

Augustyniak, Monica ; Lou, Emil ; Jacobs, Ginny...
Journal of Cancer Education.  39 (2023)  2 - p. 118-125 , 2023
Link: https://doi.org/10.1007/..
 
?
15

Tumor-infiltrating lymphocytes: Prognostic considerations a..:

, In: NK Cells in Cancer Immunotherapy: Successes and Challenges,
Folsom, Timothy D. ; Moriarity, Branden S. ; Starr, Timothy K... - p. 403-426 , 2023
Link: https://doi.org/10.1016/..
 
1-15